Suppressor of cytosine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes

被引:41
作者
Ilangumaran, S
Ramanathan, S
Ning, T
La Rose, J
Reinhart, B
Poussier, P
Rottapel, R
机构
[1] Univ Toronto, Princess Margaret Hosp, Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada
[2] Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
[3] Univ Toronto, Dept Immunol, Toronto, ON, Canada
[4] Univ Toronto, Dept Med, Toronto, ON, Canada
[5] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[6] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
关键词
D O I
10.1182/blood-2003-01-0175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SOCS1(-/-) mice die prematurely of increased interferon-gamma (IFNgamma) signaling with severe thymic atrophy and accelerated maturation of T cells. However, it was unclear whether the thymic defects were caused by SOCS1 deficiency or by increased IFNgamma signaling. Using SOCS1(-/-) IFNgamma(-/-) mice, we show in this study that SOCS1 deficiency skews thymocyte development toward CD8 lineage independently of IFNgamma. Fetal thymic organ cultures and intrathymic transfer of CD4(-)CD8(-) precursors into Rag1(-/-) mice show that the lineage skewing in SOCS1(-/-) mice is a T-cell autonomous defect. Interestingly, SOCS1 is not required for attenuating interleukin-7 (IL-7) signaling at the CD4(-)CD8(-) stage but is essential for regulating IL-15 and IL-2 signaling in CD8(+) thymocytes. IL-15 selectively stimulates SOCS1(-/-) CD8(+) thymocytes, inducing sustained signal transducer and activator of transcription 5 (STAT5) phosphorylation and massive proliferation. IL-15 also strongly upregulates Bcl-xL and CD44 in CD8(+) thymocytes lacking SOCS1. The SOCS1 gene is induced in CD4(+) thymocytes by gamma(c) cytokines, whereas CD8(+) thymocytes constitutively express SOCS1 mRNA even in the absence of cytokine stimulation. Because many different cell types express IL-15, our results strongly suggest that SOCS1 functions as an indispensable attenuator of IL-15 receptor signaling in developing CD8(+) thymocytes. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:4115 / 4122
页数:8
相关论文
共 64 条
[1]   Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice [J].
Akashi, K ;
Kondo, M ;
vonFreedenJeffry, U ;
Murray, R ;
Weissman, IL .
CELL, 1997, 89 (07) :1033-1041
[2]   Suppressors of cytokine signalling (SOCS) in the immune system [J].
Alexander, WS .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :410-416
[3]   SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine [J].
Alexander, WS ;
Starr, R ;
Fenner, JE ;
Scott, GL ;
Handman, E ;
Sprigg, NS ;
Corbin, JE ;
Cornish, AL ;
Darwiche, R ;
Owczarek, CM ;
Kay, TWH ;
Nicola, NA ;
Hertzog, PJ ;
Metcalf, D ;
Hilton, DJ .
CELL, 1999, 98 (05) :597-608
[4]   An invitation to T and more: Notch signaling in lymphopoiesis [J].
Allman, D ;
Punt, JA ;
Izon, DJ ;
Aster, JC ;
Pear, WS .
CELL, 2002, 109 :S1-S11
[5]   Lymphostromal interactions in thymic development and function [J].
Anderson, G ;
Jenkinson, EJ .
NATURE REVIEWS IMMUNOLOGY, 2001, 1 (01) :31-40
[6]  
BAIRD PN, 1996, CURR OPIN IMMUNOL, V11, P157
[7]   The CD4/CD8 lineage decision: integration of signalling pathways [J].
Basson, MA ;
Zamoyska, R .
IMMUNOLOGY TODAY, 2000, 21 (10) :509-514
[8]   Coreceptor reversal in the thymus:: Signaled CD4+8+ thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells [J].
Brugnera, E ;
Bhandoola, A ;
Cibotti, R ;
Yu, Q ;
Guinter, TI ;
Yamashita, Y ;
Sharrow, SO ;
Singer, A .
IMMUNITY, 2000, 13 (01) :59-71
[9]   DEFECTIVE LYMPHOID DEVELOPMENT IN MICE LACKING EXPRESSION OF THE COMMON CYTOKINE RECEPTOR-GAMMA CHAIN [J].
CAO, XQ ;
SHORES, EW ;
HULI, J ;
ANVER, MR ;
KELSALL, BL ;
RUSSELL, SM ;
DRAGO, J ;
NOGUCHI, M ;
GRINBERG, A ;
BLOOM, ET ;
PAUL, WE ;
KATZ, SI ;
LOVE, PE ;
LEONARD, WJ .
IMMUNITY, 1995, 2 (03) :223-238
[10]   BCL-X(L) AND BCL-2 REPRESS A COMMON PATHWAY OF CELL-DEATH [J].
CHAO, DT ;
LINETTE, GP ;
BOISE, LH ;
WHITE, LS ;
THOMPSON, CB ;
KORSMEYER, SJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :821-828